Intellia Therapeutics Ownership 2024 | Who Owns Intellia Therapeutics Now?
Institutional Ownership
94.22%
Insider Ownership
1.21%
Retail Ownership
4.57%
Institutional Holders
299.00
Intellia Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARK INVESTMENT MANAGEMENT LLC | 12.14% | 2.30% | 11,595,789 | 606,507 | 5.52% | 259,513,759 | Jun 30, 2024 |
| BLACKROCK INC. | 10.05% | 0.00% | 9,597,607 | 488,339 | 5.36% | 214,794,449 | Jun 30, 2024 |
| VANGUARD GROUP INC | 9.53% | 0.00% | 9,100,068 | 6,356 | 0.07% | 203,659,522 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 5.03% | 3.21% | 4,800,000 | 589,216 | 13.99% | 107,424,000 | Jun 30, 2024 |
| STATE STREET CORP | 4.57% | 0.00% | 4,362,780 | -235,042 | -5.11% | 97,639,016,000 | Jun 30, 2024 |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 3.41% | 0.05% | 3,257,689 | -141,629 | -4.17% | 72,907,080 | Jun 30, 2024 |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 3.41% | 0.84% | 3,257,689 | -141,629 | -4.17% | 72,907,080 | Jun 30, 2024 |
| MORGAN STANLEY | 2.45% | 0.00% | 2,337,709 | -307,142 | -11.61% | 52,317,936 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 2.41% | 0.12% | 2,300,889 | 371,189 | 19.24% | 51,493,896,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.40% | 0.00% | 2,293,943 | 249,686 | 12.21% | 51,348,583 | Jun 30, 2024 |
| FMR LLC | 2.33% | 0.00% | 2,228,418 | 22,076 | 1.00% | 49,871,987 | Jun 30, 2024 |
| CASDIN CAPITAL, LLC | 2.09% | 3.43% | 2,000,000 | 125,000 | 6.67% | 44,760,000 | Jun 30, 2024 |
| CONTRARIUS INVESTMENT MANAGEMENT LTD | 2.01% | 2.68% | 1,915,410 | 564,879 | 41.83% | 42,867,000 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 1.87% | 0.01% | 1,782,884 | 211,360 | 13.45% | 39,900,944 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.39% | 0.01% | 1,324,561 | 98,865 | 8.07% | 29,647,636 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.33% | 0.00% | 1,266,602 | 199,142 | 18.66% | 28,346,553 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.30% | 0.00% | 1,244,959 | -380,092 | -23.39% | 27,863,000 | Jun 30, 2024 |
| ROKOS CAPITAL MANAGEMENT LLP | 1.19% | 0.16% | 1,140,973 | -322,657 | -22.05% | 25,511,033 | Jun 30, 2024 |
| CHEVY CHASE TRUST HOLDINGS, LLC | 1.09% | 0.07% | 1,042,625 | -31,985 | -2.98% | 23,333,947 | Jun 30, 2024 |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1.08% | 1.63% | 1,029,982 | -639 | -0.06% | 23,050,997 | Jun 30, 2024 |
Intellia Therapeutics's largest institutional shareholder is ARK INVESTMENT MANAGEMENT LLC, holding 12.14% of the company's total share outstanding, currently valued at $259.51M. The top 10 institutional shareholders own together 55.40% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DISCOVERY VALUE FUND | 0.59% | 6.39% | 561,561 | - | - | 12,567,735 | Jun 30, 2024 |
| CASDIN CAPITAL, LLC | 2.09% | 3.43% | 2,000,000 | 125,000 | 6.67% | 44,760,000 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 5.03% | 3.21% | 4,800,000 | 589,216 | 13.99% | 107,424,000 | Jun 30, 2024 |
| CONTRARIUS INVESTMENT MANAGEMENT LTD | 2.01% | 2.68% | 1,915,410 | 564,879 | 41.83% | 42,867,000 | Jun 30, 2024 |
| ARK INVESTMENT MANAGEMENT LLC | 12.14% | 2.30% | 11,595,789 | 606,507 | 5.52% | 259,513,759 | Jun 30, 2024 |
| CAPITAL IMPACT ADVISORS, LLC | 0.03% | 1.67% | 26,554 | -5,439 | -17.00% | 594,279 | Jun 30, 2024 |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1.08% | 1.63% | 1,029,982 | -639 | -0.06% | 23,050,997 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 0.46% | 1.54% | 443,503 | 10,905 | 2.52% | 9,925,597 | Jun 30, 2024 |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 0.12% | 1.44% | 117,315 | - | - | 2,625,510 | Jun 30, 2024 |
| ORCHARD CAPITAL MANAGEMENT, LLC | 0.18% | 1.15% | 170,006 | -2,310 | -1.34% | 3,804,734 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 0.23% | 1.11% | 218,000 | -37,000 | -14.51% | 4,878,840 | Jun 30, 2024 |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 3.41% | 0.84% | 3,257,689 | -141,629 | -4.17% | 72,907,080 | Jun 30, 2024 |
| EVOLUTIONARY TREE CAPITAL MANAGEMENT, LLC | 0.04% | 0.84% | 36,262 | -508 | -1.38% | 811,544 | Jun 30, 2024 |
| LEWIS ASSET MANAGEMENT, LLC | 0.05% | 0.80% | 46,533 | 15,940 | 52.10% | 1,041,409 | Jun 30, 2024 |
| ELMWOOD WEALTH MANAGEMENT, INC. | 0.07% | 0.67% | 67,174 | -725 | -1.07% | 1,503,355 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.24% | 0.48% | 227,220 | 4,249 | 1.91% | 5,085,184 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.15% | 0.43% | 139,419 | 139,419 | 100.00% | 3,120,197 | Jun 30, 2024 |
| INTELLECTUS PARTNERS, LLC | 0.06% | 0.36% | 58,225 | 1,225 | 2.15% | 1,303,076 | Jun 30, 2024 |
| VESTMARK ADVISORY SOLUTIONS, INC. | 0.37% | 0.33% | 355,325 | -65,072 | -15.48% | 7,952,174 | Jun 30, 2024 |
| MCGUIRE INVESTMENT GROUP, LLC | 0.08% | 0.23% | 71,994 | -4,498 | -5.88% | 1,611,226 | Jun 30, 2024 |
The largest Intellia Therapeutics shareholder by % of total assets is DISCOVERY VALUE FUND. The company owns 561.56K shares of Intellia Therapeutics (NTLA), representing 6.39% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARK INVESTMENT MANAGEMENT LLC | 12.14% | 2.30% | 11,595,789 | 606,507 | 5.52% | 259,513,759 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 5.03% | 3.21% | 4,800,000 | 589,216 | 13.99% | 107,424,000 | Jun 30, 2024 |
| CONTRARIUS INVESTMENT MANAGEMENT LTD | 2.01% | 2.68% | 1,915,410 | 564,879 | 41.83% | 42,867,000 | Jun 30, 2024 |
| BLACKROCK INC. | 10.05% | 0.00% | 9,597,607 | 488,339 | 5.36% | 214,794,449 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.91% | 0.01% | 865,631 | 481,763 | 125.50% | 19,372,822 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 2.41% | 0.12% | 2,300,889 | 371,189 | 19.24% | 51,493,896,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.40% | 0.00% | 2,293,943 | 249,686 | 12.21% | 51,348,583 | Jun 30, 2024 |
| NORGES BANK | 0.25% | 0.00% | 240,415 | 240,415 | 100.00% | 5,380,488 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.25% | 0.01% | 234,815 | 234,815 | 100.00% | 5,261,519 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.87% | 0.04% | 829,285 | 214,717 | 34.94% | 18,559,398 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 1.87% | 0.01% | 1,782,884 | 211,360 | 13.45% | 39,900,944 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.33% | 0.00% | 1,266,602 | 199,142 | 18.66% | 28,346,553 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.18% | 0.06% | 170,828 | 170,828 | 100.00% | 3,823,131 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 0.18% | 0.16% | 170,000 | 170,000 | 100.00% | 3,804,600 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.20% | 0.03% | 186,440 | 160,719 | 624.86% | 4,172,525 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.36% | 0.01% | 347,483 | 158,982 | 84.34% | 7,776,670 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.15% | 0.43% | 139,419 | 139,419 | 100.00% | 3,120,197 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.54% | 0.00% | 512,309 | 132,671 | 34.95% | 11,465,475 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.70% | 0.00% | 669,105 | 125,998 | 23.20% | 14,974,570 | Jun 30, 2024 |
| CASDIN CAPITAL, LLC | 2.09% | 3.43% | 2,000,000 | 125,000 | 6.67% | 44,760,000 | Jun 30, 2024 |
As of Jun 30 2024, Intellia Therapeutics's largest institutional buyer is ARK INVESTMENT MANAGEMENT LLC. The company purchased 606.51K stocks of NTLA, valued at $259.51M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 0.82% | 0.00% | 781,774 | -3,380,355 | -81.22% | 17,496,101 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.30% | 0.00% | 1,244,959 | -380,092 | -23.39% | 27,863,000 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.47% | 0.04% | 452,448 | -343,066 | -43.13% | 10,125,786 | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -335,408 | -100.00% | - | Jun 30, 2024 |
| ROKOS CAPITAL MANAGEMENT LLP | 1.19% | 0.16% | 1,140,973 | -322,657 | -22.05% | 25,511,033 | Jun 30, 2024 |
| MORGAN STANLEY | 2.45% | 0.00% | 2,337,709 | -307,142 | -11.61% | 52,317,936 | Jun 30, 2024 |
| STATE STREET CORP | 4.57% | 0.00% | 4,362,780 | -235,042 | -5.11% | 97,639,016,000 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.01% | 0.00% | 13,280 | -232,496 | -94.60% | 297,206 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 0.00% | 0.00% | 2,880 | -214,514 | -98.68% | 66,787 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | - | - | - | -203,684 | -100.00% | - | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | - | - | - | -200,000 | -100.00% | - | Jun 30, 2024 |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 3.41% | 0.84% | 3,257,689 | -141,629 | -4.17% | 72,907,080 | Jun 30, 2024 |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 3.41% | 0.05% | 3,257,689 | -141,629 | -4.17% | 72,907,080 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.08% | 0.00% | 75,674 | -103,205 | -57.70% | 1,693,584 | Jun 30, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 0.14% | 0.01% | 138,468 | -99,532 | -41.82% | 3,098,914 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.24% | 0.02% | 225,212 | -98,349 | -30.40% | 5,040,245 | Jun 30, 2024 |
| CAPITAL FUND MANAGEMENT S.A. | - | - | - | -92,578 | -100.00% | - | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | - | - | - | -87,426 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -80,752 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | 0.27% | 0.00% | 255,551 | -76,035 | -22.93% | 5,719,231 | Jun 30, 2024 |
As of Jun 30 2024, Intellia Therapeutics's biggest institutional seller is WELLINGTON MANAGEMENT GROUP LLP. The company sold -3.38M shares of NTLA, valued at $17.50M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NORGES BANK | 0.25% | 0.00% | 240,415 | 240,415 | 100.00% | 5,380,488 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.25% | 0.01% | 234,815 | 234,815 | 100.00% | 5,261,519 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.18% | 0.06% | 170,828 | 170,828 | 100.00% | 3,823,131 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.15% | 0.43% | 139,419 | 139,419 | 100.00% | 3,120,197 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.07% | 0.11% | 70,355 | 70,355 | 100.00% | 1,575,000 | Jun 30, 2024 |
| ENGINEERS GATE MANAGER LP | 0.06% | 0.03% | 61,528 | 61,528 | 100.00% | 1,376,997 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.01% | 51,831 | 51,831 | 100.00% | 1,159,978 | Jun 30, 2024 |
| POLAR ASSET MANAGEMENT PARTNERS INC. | 0.05% | 0.02% | 45,200 | 45,200 | 100.00% | 1,011,576 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.05% | 0.01% | 43,663 | 43,663 | 100.00% | 977,178 | Jun 30, 2024 |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 0.04% | 0.05% | 39,882 | 39,882 | 100.00% | 892,559 | Jun 30, 2024 |
| CAPULA MANAGEMENT LTD | 0.04% | 0.01% | 34,187 | 34,187 | 100.00% | 765,105 | Jun 30, 2024 |
| THRIVENT FINANCIAL FOR LUTHERANS | 0.03% | 0.00% | 30,333 | 30,333 | 100.00% | 679,000 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.03% | 0.00% | 30,000 | 30,000 | 100.00% | 671,400 | Jun 30, 2024 |
| TEZA CAPITAL MANAGEMENT LLC | 0.02% | 0.06% | 20,095 | 20,095 | 100.00% | 449,726 | Jun 30, 2024 |
| ATRIA INVESTMENTS, INC | 0.02% | 0.01% | 18,588 | 18,588 | 100.00% | 416,000 | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | 0.02% | 0.00% | 17,748 | 17,748 | 100.00% | 397,200 | Jun 30, 2024 |
| IQ EQ FUND MANAGEMENT (IRELAND) LTD | 0.01% | 0.03% | 13,142 | 13,142 | 100.00% | 294,118 | Jun 30, 2024 |
| D.A. DAVIDSON & CO. | 0.01% | 0.00% | 12,100 | 12,100 | 100.00% | 270,798,000 | Jun 30, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 0.01% | 0.01% | 10,818 | 10,818 | 100.00% | 242,107 | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | 0.01% | 0.00% | 10,000 | 10,000 | 100.00% | 223,800 | Jun 30, 2024 |
| BRIDGEFRONT CAPITAL, LLC | 0.01% | 0.09% | 9,297 | 9,297 | 100.00% | 208,067 | Jun 30, 2024 |
| CLEAR STREET MARKETS LLC | 0.00% | 0.02% | 4,700 | 4,700 | 100.00% | 105,000 | Jun 30, 2024 |
| JOHNSON FINANCIAL GROUP, INC. | 0.00% | 0.00% | 3,856 | 3,856 | 100.00% | 86,298 | Jun 30, 2024 |
| SALEM INVESTMENT COUNSELORS INC | 0.00% | 0.00% | 1,250 | 1,250 | 100.00% | 27,975 | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | 0.00% | 0.00% | 700 | 700 | 100.00% | 15,666 | Jun 30, 2024 |
| MANCHESTER CAPITAL MANAGEMENT LLC | 0.00% | 0.00% | 540 | 540 | 100.00% | 12,086 | Jun 30, 2024 |
| TRUST CO OF VERMONT | 0.00% | 0.00% | 216 | 216 | 100.00% | 4,834 | Jun 30, 2024 |
| GILLILAND JETER WEALTH MANAGEMENT LLC | 0.00% | 0.00% | 212 | 212 | 100.00% | 4,745 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | 0.00% | 164 | 164 | 100.00% | 3,803 | Jun 30, 2024 |
| MOTCO | 0.00% | 0.00% | 100 | 100 | 100.00% | 2,238 | Jun 30, 2024 |
| REDWOOD WEALTH MANAGEMENT GROUP, LLC | 0.00% | 0.00% | 100 | 100 | 100.00% | 2,238 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | - | 0.00% | 18 | 18 | 100.00% | 403 | Jun 30, 2024 |
| FAMILY FIRM, INC. | - | 0.00% | 15 | 15 | 100.00% | 336 | Jun 30, 2024 |
| BALDWIN BROTHERS LLC/MA | - | - | 4 | 4 | 100.00% | 90 | Jun 30, 2024 |
| PLANNING CAPITAL MANAGEMENT CORP | - | - | 3 | 3 | 100.00% | 68 | Jun 30, 2024 |
| IFP ADVISORS, INC | - | - | 1 | 1 | 100.00% | 22 | Jun 30, 2024 |
| ACTIVEST WEALTH MANAGEMENT | - | - | 1 | 1 | 100.00% | 22 | Jun 30, 2024 |
Intellia Therapeutics's largest new institutional shareholder by number of shares is NORGES BANK, purchased 240.41K shares, valued at $5.38M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MARSHALL WACE, LLP | - | - | - | -335,408 | -100.00% | - | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | - | - | - | -203,684 | -100.00% | - | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | - | - | - | -200,000 | -100.00% | - | Jun 30, 2024 |
| CAPITAL FUND MANAGEMENT S.A. | - | - | - | -92,578 | -100.00% | - | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | - | - | - | -87,426 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -80,752 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -52,560 | -100.00% | - | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | - | - | - | -51,438 | -100.00% | - | Jun 30, 2024 |
| CASDIN CAPITAL, LLC | - | - | - | -50,000 | -100.00% | - | Jun 30, 2024 |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | - | - | - | -48,000 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -47,986 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -44,588 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -44,180 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -43,000 | -100.00% | - | Jun 30, 2024 |
| TD ASSET MANAGEMENT INC | - | - | - | -30,692 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -29,144 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -23,159 | -100.00% | - | Jun 30, 2024 |
| BLAIR WILLIAM & CO/IL | - | - | - | -10,307 | -100.00% | - | Jun 30, 2024 |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | - | - | - | -8,944 | -100.00% | - | Jun 30, 2024 |
| PRIVIUM FUND MANAGEMENT B.V. | - | - | - | -8,905 | -100.00% | - | Jun 30, 2024 |
| SECTORAL ASSET MANAGEMENT INC | - | - | - | -8,800 | -100.00% | - | Jun 30, 2024 |
| AZZAD ASSET MANAGEMENT INC /ADV | - | - | - | -8,496 | -100.00% | - | Jun 30, 2024 |
| STEEL PEAK WEALTH MANAGEMENT LLC | - | - | - | -8,309 | -100.00% | - | Jun 30, 2024 |
| CYNDEO WEALTH PARTNERS, LLC | - | - | - | -8,224 | -100.00% | - | Jun 30, 2024 |
| AXA S.A. | - | - | - | -8,223 | -100.00% | - | Jun 30, 2024 |
| GREEN ALPHA ADVISORS, LLC | - | - | - | -7,964 | -100.00% | - | Jun 30, 2024 |
| QUADCAP WEALTH MANAGEMENT, LLC | - | - | - | -7,916 | -100.00% | - | Jun 30, 2024 |
| NOMURA HOLDINGS INC | - | - | - | -7,740 | -100.00% | - | Jun 30, 2024 |
| FORT SHERIDAN ADVISORS LLC | - | - | - | -7,478 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -4,830 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -4,739 | -100.00% | - | Jun 30, 2024 |
| NATIXIS | - | - | - | -2,045 | -100.00% | - | Jun 30, 2024 |
| BANK JULIUS BAER & CO. LTD, ZURICH | - | - | - | -1,897 | -100.00% | - | Jun 30, 2024 |
| QUARRY LP | - | - | - | -1,800 | -100.00% | - | Jun 30, 2024 |
| NVERSES CAPITAL, LLC | - | - | - | -1,100 | -100.00% | - | Jun 30, 2024 |
| FIFTH THIRD BANCORP | - | - | - | -150 | -100.00% | - | Jun 30, 2024 |
| NEWEDGE ADVISORS, LLC | - | - | - | -40 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -17 | -100.00% | - | Jun 30, 2024 |
Intellia Therapeutics's largest sold out institutional shareholder by shares sold is MARSHALL WACE, LLP, sold -0.34M shares, valued at -, as of undefined.
Intellia Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| AGF Investments Trust | 1.93% | -36,494 | -182 | 0.50% | Mar 31, 2024 |
| Tema ETF Trust | 1.44% | 64,083 | 34,883 | 119.46% | Feb 29, 2024 |
| Ark ETF Trust | 1.19% | 9,591,168 | -302,330 | -3.06% | Jan 31, 2024 |
| LORD ABBETT DEVELOPING GROWTH FUND, INC. | 0.34% | 318,109 | - | - | Jan 31, 2024 |
| Kelly Strategic ETF Trust | 0.28% | 7,616 | - | - | Feb 29, 2024 |
| AB DISCOVERY GROWTH FUND, INC. | 0.22% | 323,313 | 38,300 | 13.44% | Jan 31, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.19% | 387,714 | - | - | Feb 29, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.17% | 33,398 | 17,160 | 105.68% | Mar 28, 2024 |
| HARTFORD HLS SERIES FUND II INC | 0.17% | 42,254 | -12,909 | -23.40% | Dec 31, 2023 |
| T. Rowe Price New Horizons Fund, Inc. | 0.15% | 727,740 | -100,924 | -12.18% | Mar 31, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.12% | 103,664 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.11% | 57,738 | - | - | Mar 31, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.11% | 354,550 | 4,686 | 1.34% | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.11% | 50,605 | - | - | Mar 31, 2024 |
| EntrepreneurShares Series Trust | 0.10% | 26,128 | 14,750 | 129.64% | Dec 31, 2023 |
| Federated Hermes Equity Funds | 0.10% | 1,905,000 | -85,000 | -4.27% | Jan 31, 2024 |
| SIT MUTUAL FUNDS INC | 0.07% | 26,625 | 1,825 | 7.36% | Mar 28, 2024 |
| Ark Venture Fund | 0.07% | 6,595 | 1,002 | 17.92% | Jan 31, 2024 |
| WANGER ADVISORS TRUST | 0.07% | 35,484 | - | - | Mar 31, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.06% | 235,686 | - | - | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.06% | 541,600 | - | - | Jan 31, 2024 |
| Nuveen NASDAQ 100 Dynamic Overwrite Fund | 0.06% | 7,590 | - | - | Mar 31, 2024 |
| PRUDENTIAL JENNISON MID-CAP GROWTH FUND, INC. | 0.06% | 122,689 | - | - | Feb 29, 2024 |
| COLUMBIA ACORN TRUST | 0.06% | 194,614 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.05% | 128,820 | - | - | Mar 31, 2024 |
| RMB INVESTORS TRUST | 0.05% | 24,233 | 1,364 | 5.96% | Dec 31, 2023 |
| Humankind Benefit Corp | 0.05% | 1,019 | 258 | 33.90% | Dec 31, 2023 |
| PRUDENTIAL JENNISON BLEND FUND, INC. | 0.04% | 27,815 | 5,521 | 24.76% | Feb 29, 2024 |
| SHELTON FUNDS | 0.04% | 66,500 | - | - | Feb 29, 2024 |
| PRUDENTIAL JENNISON SMALL CO FUND, INC. | 0.04% | 159,054 | - | - | Mar 28, 2024 |
| TOCQUEVILLE TRUST | 0.04% | 5,000 | - | - | Jan 31, 2024 |
| Gabelli ETFs Trust | 0.03% | 400 | - | - | Dec 29, 2023 |
| VANGUARD SPECIALIZED FUNDS | 0.03% | 1,534,651 | - | - | Jan 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.03% | 224,253 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.03% | 70,000 | -2,000 | -2.78% | Mar 31, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.03% | 13,270 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.03% | 155,762 | -4,884 | -3.04% | Mar 31, 2024 |
| BlackRock Health Sciences Trust | 0.03% | 6,335 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 13,257 | -169 | -1.26% | Mar 31, 2024 |
| Voya VARIABLE PRODUCTS TRUST | 0.02% | 7,215 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.02% | 8,013,043 | -624,867 | -7.23% | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.02% | 1,163,722 | 207,021 | 21.64% | Feb 29, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.02% | 20,000 | - | - | Mar 28, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.02% | 55,377 | -120,009 | -68.43% | Mar 31, 2024 |
| ALGER FUNDS | 0.02% | 14,432 | - | - | Jan 31, 2024 |
| AB CAP FUND, INC. | 0.01% | 499,229 | 35,233 | 7.59% | Jan 31, 2024 |
| Voya EQUITY TRUST | 0.01% | 19,913 | -2,870 | -12.60% | Feb 29, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.01% | 386,675 | - | - | Feb 29, 2024 |
| Federated Hermes MDT Series | 0.01% | 31,518 | - | - | Jan 31, 2024 |
| FIDELITY DESTINY PORTFOLIOS | 0.01% | 25,900 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.01% | 128,781 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY MUTUAL FUNDS, INC. | 0.01% | 103,689 | - | - | Jan 31, 2024 |
| Bernstein Fund Inc | 0.01% | 83,660 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 2,093 | - | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 27,419 | 434 | 1.61% | Feb 29, 2024 |
| Gabelli Healthcare & WellnessRx Trust | 0.01% | 1,000 | - | - | Dec 29, 2023 |
| SunAmerica Specialty Series | 0.01% | 4,234 | - | - | Apr 30, 2021 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.01% | 30,361 | - | - | Jan 31, 2024 |
| RYDEX SERIES FUNDS | 0.01% | 28,603 | -1,083 | -3.65% | Dec 31, 2023 |
| SCHWAB CAPITAL TRUST | 0.01% | 262,080 | 18,926 | 7.78% | Jan 31, 2024 |
| KINETICS PORTFOLIOS TRUST | 0.01% | 10,000 | - | - | Mar 31, 2024 |
| FEDERATED HERMES INSURANCE SERIES | 0.01% | 24,700 | -600 | -2.37% | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.01% | 53,637 | - | - | Mar 31, 2024 |
| ALPS ETF Trust | 0.01% | 67,265 | 19,222 | 40.01% | Feb 29, 2024 |
| AIM GROWTH SERIES (INVESCO GROWTH SERIES) | 0.01% | 159,568 | - | - | Mar 31, 2024 |
| JNL VARIABLE FUND LLC | 0.00% | 24,996 | - | - | Mar 31, 2020 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 872,714 | 55,980 | 6.85% | Feb 29, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.00% | 35,344 | - | - | Mar 28, 2024 |
| FIDELITY PURITAN TRUST | 0.00% | 204,644 | - | - | Jan 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.00% | 5,973 | -2,300 | -27.80% | Mar 31, 2024 |
| VELA Funds | 0.00% | 1,215 | - | - | Dec 31, 2023 |
| MORGAN STANLEY INSTITUTIONAL FUND INC | 0.00% | 239,650 | -4,149 | -1.70% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENT TRUST | 0.00% | 10,438 | - | - | Jan 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 9,133 | - | - | Mar 31, 2024 |
| Morgan Stanley Insight Fund | 0.00% | 50,745 | - | - | Mar 31, 2024 |
| Listed Funds Trust | 0.00% | 14,396 | - | - | Mar 31, 2024 |
| John Hancock Exchange-Traded Fund Trust | 0.00% | 17,646 | - | - | Jan 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.00% | 140,000 | -10,000 | -6.67% | Mar 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 3,076 | -1,030 | -25.09% | Dec 31, 2023 |
| Goldman Sachs ETF Trust II | 0.00% | 2,673 | - | - | Feb 29, 2024 |
| VANGUARD EXPLORER FUND | 0.00% | 30,463 | 8,173 | 36.67% | Jan 31, 2024 |
| ETF Managers Trust | 0.00% | 18,663 | - | - | Dec 31, 2023 |
| GABELLI EQUITY TRUST INC | 0.00% | 3,000 | - | - | Dec 29, 2023 |
| FIDELITY CONTRAFUND | 0.00% | 144,147 | - | - | Mar 31, 2024 |
| AMERICAN PENSION INVESTORS TRUST | 0.00% | 12,700 | - | - | Jan 31, 2024 |
| Harbor ETF Trust | 0.00% | 9,754 | 1,742 | 21.74% | Jan 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 315,907 | 115,164 | 57.37% | Jan 31, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 13,455 | -8,857 | -39.70% | Aug 31, 2023 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 58,314 | -810 | -1.37% | Mar 31, 2024 |
| UBS FUNDS | 0.00% | 9,236 | - | - | Mar 31, 2024 |
| HARTFORD SERIES FUND INC | 0.00% | 77,721 | 35,466 | 83.93% | Mar 31, 2024 |
| ETFis Series Trust I | 0.00% | 2,576 | 384 | 17.52% | Jan 31, 2024 |
| Destra Investment Trust | 0.00% | 2,930 | -940 | -24.29% | Mar 31, 2024 |
| Investment Managers Series Trust II | 0.00% | 21,658 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.00% | 35,000 | -5,000 | -12.50% | Mar 31, 2024 |
| FORUM FUNDS II | 0.00% | 1,600 | - | - | Jan 31, 2024 |
| NEUBERGER BERMAN EQUITY FUNDS | 0.00% | 15,421 | - | - | Feb 29, 2024 |
| BARON SELECT FUNDS | 0.00% | 16,200 | - | - | Mar 31, 2024 |
| AB VARIABLE PRODUCTS SERIES FUND, INC. | 0.00% | 7,015 | -696 | -9.03% | Mar 31, 2024 |
| NORTHERN LIGHTS FUND TRUST III | 0.00% | 18,200 | - | - | Jan 31, 2024 |
Intellia Therapeutics's largest mutual fund holder by % of total assets is "AGF Investments Trust", owning -36.49K shares, compromising 1.93% of its total assets.
Intellia Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 299 | -0.33% |
| 31 Mar, 24 | 300 | -2.28% |
| 31 Dec, 23 | 307 | 4.07% |
| 30 Sep, 23 | 295 | -1.67% |
| 30 Jun, 23 | 300 | -0.33% |
| 31 Mar, 23 | 301 | -4.44% |
| 31 Dec, 22 | 315 | -7.35% |
| 30 Sep, 22 | 340 | 7.94% |
| 30 Jun, 22 | 315 | -13.70% |
| 31 Mar, 22 | 365 | -5.44% |
| 31 Dec, 21 | 386 | 1.05% |
| 30 Sep, 21 | 382 | 1.87% |
| 30 Jun, 21 | 375 | 33.45% |
| 31 Mar, 21 | 281 | 11.07% |
| 31 Dec, 20 | 253 | 50.60% |
| 30 Sep, 20 | 168 | - |
| 30 Jun, 20 | 168 | 17.48% |
| 31 Mar, 20 | 143 | -5.92% |
| 31 Dec, 19 | 152 | 7.80% |
| 30 Sep, 19 | 141 | -6.00% |
| 30 Jun, 19 | 150 | -2.60% |
| 31 Mar, 19 | 154 | 6.94% |
| 31 Dec, 18 | 144 | -13.25% |
| 30 Sep, 18 | 166 | 2.47% |
| 30 Jun, 18 | 162 | 19.12% |
| 31 Mar, 18 | 136 | 14.29% |
| 31 Dec, 17 | 119 | 35.23% |
| 30 Sep, 17 | 88 | 1.15% |
| 30 Jun, 17 | 87 | 12.99% |
| 31 Mar, 17 | 77 | 13.24% |
| 31 Dec, 16 | 68 | 4.62% |
| 30 Sep, 16 | 65 | 4.84% |
| 30 Jun, 16 | 62 | 6100.00% |
| 31 Mar, 16 | 1 | - |
| 31 Mar, 10 | 1 | - |
As of 30 Jun 24, 299 institutions are holding Intellia Therapeutics's shares, representing a decrease of -0.33% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 89,984,596 | -0.74% |
| 31 Mar, 24 | 90,656,601 | 6.41% |
| 31 Dec, 23 | 85,199,452 | 6.57% |
| 30 Sep, 23 | 79,946,745 | 2.21% |
| 30 Jun, 23 | 78,214,958 | -0.57% |
| 31 Mar, 23 | 78,663,821 | 0.90% |
| 31 Dec, 22 | 77,962,930 | 14.61% |
| 30 Sep, 22 | 68,025,381 | 0.67% |
| 30 Jun, 22 | 67,574,966 | 3.90% |
| 31 Mar, 22 | 65,037,743 | 1.36% |
| 31 Dec, 21 | 64,165,976 | 3.25% |
| 30 Sep, 21 | 62,143,612 | -0.17% |
| 30 Jun, 21 | 62,250,713 | -1.38% |
| 31 Mar, 21 | 63,119,690 | 2.16% |
| 31 Dec, 20 | 61,787,835 | 9.51% |
| 30 Sep, 20 | 56,421,893 | 4.67% |
| 30 Jun, 20 | 53,904,837 | 16.01% |
| 31 Mar, 20 | 46,466,714 | 1.91% |
| 31 Dec, 19 | 45,595,757 | 3.44% |
| 30 Sep, 19 | 44,079,636 | 13.62% |
| 30 Jun, 19 | 38,794,359 | 14.13% |
| 31 Mar, 19 | 33,991,052 | 7.91% |
| 31 Dec, 18 | 31,498,751 | 8.14% |
| 30 Sep, 18 | 29,126,508 | 1.30% |
| 30 Jun, 18 | 28,754,040 | 9.51% |
| 31 Mar, 18 | 26,256,427 | 8.45% |
| 31 Dec, 17 | 24,211,633 | 37.16% |
| 30 Sep, 17 | 17,651,960 | 5.05% |
| 30 Jun, 17 | 16,803,583 | 0.39% |
| 31 Mar, 17 | 16,739,061 | -8.90% |
| 31 Dec, 16 | 18,374,979 | 28.91% |
| 30 Sep, 16 | 14,253,845 | 0.53% |
| 30 Jun, 16 | 14,178,702 | 6594645.12% |
| 31 Mar, 16 | 215 | - |
| 31 Mar, 10 | 223 | - |
Intellia Therapeutics (NTLA) has 89.98M shares outstanding as of 30 Jun 24, down -0.74% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 94.22% | 1.05% |
| 31 Mar, 24 | 94.93% | 1.03% |
| 31 Dec, 23 | 95.98% | 1.18% |
| 30 Sep, 23 | 90.19% | 1.15% |
| 30 Jun, 23 | 88.69% | 1.10% |
| 31 Mar, 23 | 89.62% | 0.87% |
| 31 Dec, 22 | 101.29% | 1.27% |
| 30 Sep, 22 | 89.45% | 1.12% |
| 30 Jun, 22 | 89.27% | 1.18% |
| 31 Mar, 22 | 87.01% | 1.17% |
| 31 Dec, 21 | 86.21% | 1.21% |
| 30 Sep, 21 | 84.31% | 1.01% |
| 30 Jun, 21 | 91.32% | 1.03% |
| 31 Mar, 21 | 93.95% | 0.77% |
| 31 Dec, 20 | 110.36% | 1.20% |
| 30 Sep, 20 | 96.03% | 0.94% |
| 30 Jun, 20 | 101.00% | 1.19% |
| 31 Mar, 20 | 92.03% | 0.99% |
| 31 Dec, 19 | 96.51% | 1.17% |
| 30 Sep, 19 | 90.78% | 1.27% |
| 30 Jun, 19 | 84.68% | 1.50% |
| 31 Mar, 19 | 75.14% | 1.40% |
| 31 Dec, 18 | 73.14% | 1.61% |
| 30 Sep, 18 | 67.48% | 1.50% |
| 30 Jun, 18 | 67.13% | 1.72% |
| 31 Mar, 18 | 62.45% | 1.63% |
| 31 Dec, 17 | 61.84% | 2.46% |
| 30 Sep, 17 | 50.16% | 2.17% |
| 30 Jun, 17 | 48.13% | 2.07% |
| 31 Mar, 17 | 48.21% | 1.70% |
| 31 Dec, 16 | 53.25% | 3.12% |
| 30 Sep, 16 | 41.31% | 0.75% |
| 30 Jun, 16 | 74.15% | 5076860425.00% |
| 31 Mar, 16 | 0.00% | - |
| 31 Mar, 10 | 0.00% | - |
As of 30 Jun 24, Intellia Therapeutics is held by 94.22% institutional shareholders, representing a 1.05% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 159 | 4.61% |
| 31 Mar, 24 | 152 | -11.11% |
| 31 Dec, 23 | 171 | 14.77% |
| 30 Sep, 23 | 149 | 7.97% |
| 30 Jun, 23 | 138 | -3.50% |
| 31 Mar, 23 | 143 | -13.33% |
| 31 Dec, 22 | 165 | 1.23% |
| 30 Sep, 22 | 163 | 17.27% |
| 30 Jun, 22 | 139 | -13.66% |
| 31 Mar, 22 | 161 | -13.44% |
| 31 Dec, 21 | 186 | -8.82% |
| 30 Sep, 21 | 204 | 5.70% |
| 30 Jun, 21 | 193 | 13.53% |
| 31 Mar, 21 | 170 | 1.80% |
| 31 Dec, 20 | 167 | 83.52% |
| 30 Sep, 20 | 91 | -11.65% |
| 30 Jun, 20 | 103 | 58.46% |
| 31 Mar, 20 | 65 | -9.72% |
| 31 Dec, 19 | 72 | 18.03% |
| 30 Sep, 19 | 61 | -14.08% |
| 30 Jun, 19 | 71 | -4.05% |
| 31 Mar, 19 | 74 | 25.42% |
| 31 Dec, 18 | 59 | -1.67% |
| 30 Sep, 18 | 60 | -38.14% |
| 30 Jun, 18 | 97 | 22.78% |
| 31 Mar, 18 | 79 | -3.66% |
| 31 Dec, 17 | 82 | 78.26% |
| 30 Sep, 17 | 46 | -19.30% |
| 30 Jun, 17 | 57 | 32.56% |
| 31 Mar, 17 | 43 | 19.44% |
| 31 Dec, 16 | 36 | - |
| 30 Sep, 16 | 36 | -41.94% |
| 30 Jun, 16 | 62 | 6100.00% |
| 31 Mar, 16 | 1 | - |
| 31 Mar, 10 | 1 | - |
159 institutional shareholders have increased their position in NTLA stock as of 30 Jun 24 compared to 152 in the previous quarter (a 4.61% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 84 | -4.55% |
| 31 Mar, 24 | 88 | 10.00% |
| 31 Dec, 23 | 80 | 19.40% |
| 30 Sep, 23 | 67 | -11.84% |
| 30 Jun, 23 | 76 | -16.48% |
| 31 Mar, 23 | 91 | 8.33% |
| 31 Dec, 22 | 84 | -15.15% |
| 30 Sep, 22 | 99 | 4.21% |
| 30 Jun, 22 | 95 | -20.17% |
| 31 Mar, 22 | 119 | -2.46% |
| 31 Dec, 21 | 122 | 9.91% |
| 30 Sep, 21 | 111 | -0.89% |
| 30 Jun, 21 | 112 | 83.61% |
| 31 Mar, 21 | 61 | 24.49% |
| 31 Dec, 20 | 49 | 40.00% |
| 30 Sep, 20 | 35 | 25.00% |
| 30 Jun, 20 | 28 | -17.65% |
| 31 Mar, 20 | 34 | 17.24% |
| 31 Dec, 19 | 29 | -14.71% |
| 30 Sep, 19 | 34 | 36.00% |
| 30 Jun, 19 | 25 | -10.71% |
| 31 Mar, 19 | 28 | -31.71% |
| 31 Dec, 18 | 41 | -24.07% |
| 30 Sep, 18 | 54 | 92.86% |
| 30 Jun, 18 | 28 | 7.69% |
| 31 Mar, 18 | 26 | 85.71% |
| 31 Dec, 17 | 14 | -17.65% |
| 30 Sep, 17 | 17 | 70.00% |
| 30 Jun, 17 | 10 | -44.44% |
| 31 Mar, 17 | 18 | 28.57% |
| 31 Dec, 16 | 14 | - |
| 30 Sep, 16 | 14 | - |
| 30 Jun, 16 | - | - |
| 31 Mar, 16 | - | - |
| 31 Mar, 10 | - | - |
84 institutional shareholders have reduced their position in NTLA stock as of 30 Jun 24 compared to 88 in the previous quarter (a -4.55% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 299 | -0.33% | 89,984,596 | -0.74% | 94.22% | 1.05% | 159 | 4.61% | 84 | -4.55% |
| 31 Mar, 24 | 300 | -2.28% | 90,656,601 | 6.41% | 94.93% | 1.03% | 152 | -11.11% | 88 | 10.00% |
| 31 Dec, 23 | 307 | 4.07% | 85,199,452 | 6.57% | 95.98% | 1.18% | 171 | 14.77% | 80 | 19.40% |
| 30 Sep, 23 | 295 | -1.67% | 79,946,745 | 2.21% | 90.19% | 1.15% | 149 | 7.97% | 67 | -11.84% |
| 30 Jun, 23 | 300 | -0.33% | 78,214,958 | -0.57% | 88.69% | 1.10% | 138 | -3.50% | 76 | -16.48% |
| 31 Mar, 23 | 301 | -4.44% | 78,663,821 | 0.90% | 89.62% | 0.87% | 143 | -13.33% | 91 | 8.33% |
| 31 Dec, 22 | 315 | -7.35% | 77,962,930 | 14.61% | 101.29% | 1.27% | 165 | 1.23% | 84 | -15.15% |
| 30 Sep, 22 | 340 | 7.94% | 68,025,381 | 0.67% | 89.45% | 1.12% | 163 | 17.27% | 99 | 4.21% |
| 30 Jun, 22 | 315 | -13.70% | 67,574,966 | 3.90% | 89.27% | 1.18% | 139 | -13.66% | 95 | -20.17% |
| 31 Mar, 22 | 365 | -5.44% | 65,037,743 | 1.36% | 87.01% | 1.17% | 161 | -13.44% | 119 | -2.46% |
| 31 Dec, 21 | 386 | 1.05% | 64,165,976 | 3.25% | 86.21% | 1.21% | 186 | -8.82% | 122 | 9.91% |
| 30 Sep, 21 | 382 | 1.87% | 62,143,612 | -0.17% | 84.31% | 1.01% | 204 | 5.70% | 111 | -0.89% |
| 30 Jun, 21 | 375 | 33.45% | 62,250,713 | -1.38% | 91.32% | 1.03% | 193 | 13.53% | 112 | 83.61% |
| 31 Mar, 21 | 281 | 11.07% | 63,119,690 | 2.16% | 93.95% | 0.77% | 170 | 1.80% | 61 | 24.49% |
| 31 Dec, 20 | 253 | 50.60% | 61,787,835 | 9.51% | 110.36% | 1.20% | 167 | 83.52% | 49 | 40.00% |
| 30 Sep, 20 | 168 | - | 56,421,893 | 4.67% | 96.03% | 0.94% | 91 | -11.65% | 35 | 25.00% |
| 30 Jun, 20 | 168 | 17.48% | 53,904,837 | 16.01% | 101.00% | 1.19% | 103 | 58.46% | 28 | -17.65% |
| 31 Mar, 20 | 143 | -5.92% | 46,466,714 | 1.91% | 92.03% | 0.99% | 65 | -9.72% | 34 | 17.24% |
| 31 Dec, 19 | 152 | 7.80% | 45,595,757 | 3.44% | 96.51% | 1.17% | 72 | 18.03% | 29 | -14.71% |
| 30 Sep, 19 | 141 | -6.00% | 44,079,636 | 13.62% | 90.78% | 1.27% | 61 | -14.08% | 34 | 36.00% |
| 30 Jun, 19 | 150 | -2.60% | 38,794,359 | 14.13% | 84.68% | 1.50% | 71 | -4.05% | 25 | -10.71% |
| 31 Mar, 19 | 154 | 6.94% | 33,991,052 | 7.91% | 75.14% | 1.40% | 74 | 25.42% | 28 | -31.71% |
| 31 Dec, 18 | 144 | -13.25% | 31,498,751 | 8.14% | 73.14% | 1.61% | 59 | -1.67% | 41 | -24.07% |
| 30 Sep, 18 | 166 | 2.47% | 29,126,508 | 1.30% | 67.48% | 1.50% | 60 | -38.14% | 54 | 92.86% |
| 30 Jun, 18 | 162 | 19.12% | 28,754,040 | 9.51% | 67.13% | 1.72% | 97 | 22.78% | 28 | 7.69% |
| 31 Mar, 18 | 136 | 14.29% | 26,256,427 | 8.45% | 62.45% | 1.63% | 79 | -3.66% | 26 | 85.71% |
| 31 Dec, 17 | 119 | 35.23% | 24,211,633 | 37.16% | 61.84% | 2.46% | 82 | 78.26% | 14 | -17.65% |
| 30 Sep, 17 | 88 | 1.15% | 17,651,960 | 5.05% | 50.16% | 2.17% | 46 | -19.30% | 17 | 70.00% |
| 30 Jun, 17 | 87 | 12.99% | 16,803,583 | 0.39% | 48.13% | 2.07% | 57 | 32.56% | 10 | -44.44% |
| 31 Mar, 17 | 77 | 13.24% | 16,739,061 | -8.90% | 48.21% | 1.70% | 43 | 19.44% | 18 | 28.57% |
| 31 Dec, 16 | 68 | 4.62% | 18,374,979 | 28.91% | 53.25% | 3.12% | 36 | - | 14 | - |
| 30 Sep, 16 | 65 | 4.84% | 14,253,845 | 0.53% | 41.31% | 0.75% | 36 | -41.94% | 14 | - |
| 30 Jun, 16 | 62 | 6100.00% | 14,178,702 | 6594645.12% | 74.15% | 5076860425.00% | 62 | 6100.00% | - | - |
| 31 Mar, 16 | 1 | - | 215 | - | 0.00% | - | 1 | - | - | - |
| 31 Mar, 10 | 1 | - | 223 | - | 0.00% | - | 1 | - | - | - |
Intellia Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Intellia Therapeutics's stock was made by Clark Eliana on Jul 03 2024, selling 405 shares at $22.93 per share (valued at $9.29K).
Intellia Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 3 | 1 | 300.00% |
| Q2 2024 | 14 | 2 | 700.00% |
| Q1 2024 | 18 | 16 | 112.50% |
| Q4 2023 | - | 1 | - |
| Q3 2023 | - | 3 | - |
| Q2 2023 | 17 | 3 | 566.67% |
| Q1 2023 | 20 | 15 | 133.33% |
| Q2 2022 | 14 | - | - |
| Q1 2022 | 23 | 8 | 287.50% |
| Q4 2021 | 4 | 19 | 21.05% |
| Q3 2021 | 21 | 74 | 28.38% |
| Q2 2021 | 27 | 68 | 39.71% |
| Q1 2021 | 25 | 46 | 54.35% |
| Q4 2020 | 31 | 44 | 70.45% |
| Q3 2020 | 6 | 12 | 50.00% |
| Q2 2020 | 10 | 6 | 166.67% |
| Q1 2020 | 6 | - | - |
| Q3 2019 | 1 | - | - |
| Q2 2019 | 7 | - | - |
| Q1 2019 | 4 | - | - |
3 total buy trades, and 1 total sell trades (buy/sell ratio of 3.00%) were made by Intellia Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 1 | - |
| Q2 2024 | - | 1 | - |
| Q1 2024 | - | 12 | - |
| Q4 2023 | - | 1 | - |
| Q3 2023 | - | 3 | - |
| Q2 2023 | - | 1 | - |
| Q1 2023 | - | 11 | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | 4 | - |
| Q4 2021 | - | 15 | - |
| Q3 2021 | - | 54 | - |
| Q2 2021 | - | 59 | - |
| Q1 2021 | - | 33 | - |
| Q4 2020 | - | 22 | - |
| Q3 2020 | - | 6 | - |
| Q2 2020 | - | 3 | - |
| Q1 2020 | - | - | - |
| Q3 2019 | - | - | - |
| Q2 2019 | - | - | - |
| Q1 2019 | 2 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Intellia Therapeutics's stocks.
Intellia Therapeutics Peer Ownership
NTLA Ownership FAQ
Who Owns Intellia Therapeutics?
Intellia Therapeutics is owned by institutional shareholders (94.22%), insiders (1.21%), and public (4.57%). The largest institutional shareholder of Intellia Therapeutics is ARK INVESTMENT MANAGEMENT LLC (12.14% of total shares) and the top mutual fund owner is AGF Investments Trust (1.93% of total shares).
Who are the major institutional shareholders of Intellia Therapeutics?
Intellia Therapeutics's major institutional shareholders are ARK INVESTMENT MANAGEMENT LLC, BLACKROCK INC., VANGUARD GROUP INC, DEEP TRACK CAPITAL, LP, and STATE STREET CORP. The top five shareholders own together 41.31% of the company's share outstanding.
How many Intellia Therapeutics shareholders are there?
As of Jun 2024, there are 299 institutional shareholders of Intellia Therapeutics.
What percentage of Intellia Therapeutics is owned by ARK INVESTMENT MANAGEMENT LLC?
ARK INVESTMENT MANAGEMENT LLC owns 11.6M shares of Intellia Therapeutics, representing 12.14% of the company's total shares outstanding, valued at $259.51M (as of Jun 2024).
What percentage of Intellia Therapeutics is owned by BLACKROCK INC?
As of Jun 2024, BLACKROCK INC holds 9.6M shares of Intellia Therapeutics (NTLA), compromising 10.05% of the company, valued at $214.79M.
What percentage of Intellia Therapeutics is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC is the third largest holder of Intellia Therapeutics. The company owns 9.1M of the company's shares outstanding (worth $203.66M).